| - GRCh37:
- Chr16:56509484-56509486
- GRCh38:
- Chr16:56475572-56475574
| BBS2, OGFOD1 | | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74 | Uncertain significance (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56531762
- GRCh38:
- Chr16:56497850
| BBS2 | A564S | Bardet-Biedl syndrome 2 | Uncertain significance (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56534889-56534890
- GRCh38:
- Chr16:56500977-56500978
| BBS2 | G425fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56539864
- GRCh38:
- Chr16:56505952
| BBS2 | K268* | Bardet-Biedl syndrome 2 | Likely pathogenic (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56534809-56534810
- GRCh38:
- Chr16:56500897-56500898
| BBS2 | P452fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56531705
- GRCh38:
- Chr16:56497793
| BBS2 | E583* | Bardet-Biedl syndrome 2 | Likely pathogenic (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56539881-56539882
- GRCh38:
- Chr16:56505969-56505970
| BBS2 | T262fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56539900
- GRCh38:
- Chr16:56505988
| BBS2 | G256* | Bardet-Biedl syndrome 2 | Likely pathogenic (Dec 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56532353-56532354
- GRCh38:
- Chr16:56498441-56498442
| BBS2 | G552fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Dec 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56548400-56548401
- GRCh38:
- Chr16:56514488-56514489
| BBS2 | D104fs | Bardet-Biedl syndrome 2 | Likely pathogenic (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56531752
- GRCh38:
- Chr16:56497840
| BBS2 | I567fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Apr 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56540058
- GRCh38:
- Chr16:56506146
| BBS2 | K231* | Bardet-Biedl syndrome 2 | Likely pathogenic (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56540129-56540130
- GRCh38:
- Chr16:56506217-56506218
| BBS2 | T207fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56533756
- GRCh38:
- Chr16:56499844
| BBS2 | S488fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56544804-56544814
- GRCh38:
- Chr16:56510892-56510902
| BBS2 | N164fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56534902-56534918
- GRCh38:
- Chr16:56500990-56501006
| BBS2 | L416fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56534901-56534903
- GRCh38:
- Chr16:56500989-56500991
| BBS2 | E420fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Mar 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56531656-56531657
- GRCh38:
- Chr16:56497744-56497745
| BBS2 | K599fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56535402
- GRCh38:
- Chr16:56501490
| BBS2 | L363* | Bardet-Biedl syndrome 2 | Likely pathogenic (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56533714-56533715
- GRCh38:
- Chr16:56499802-56499803
| BBS2 | F501fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56534849-56534850
- GRCh38:
- Chr16:56500937-56500938
| BBS2 | S439fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Jan 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56545138
- GRCh38:
- Chr16:56511226
| BBS2 | L135H | Bardet-Biedl syndrome 2 | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56532464
- GRCh38:
- Chr16:56498552
| BBS2 | G515fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Jun 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56548494
- GRCh38:
- Chr16:56514582
| BBS2 | | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Likely benign (Oct 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56543852
- GRCh38:
- Chr16:56509940
| BBS2 | | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56536215
- GRCh38:
- Chr16:56502303
| BBS2 | | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Benign/Likely benign (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56543851
- GRCh38:
- Chr16:56509939
| BBS2 | | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Likely benign (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56530944
- GRCh38:
- Chr16:56497032
| BBS2 | | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Likely benign (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56536715
- GRCh38:
- Chr16:56502803
| BBS2 | | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56532495
- GRCh38:
- Chr16:56498583
| BBS2 | | Bardet-Biedl syndrome, Retinitis pigmentosa 74, Bardet-Biedl syndrome 2
| Likely benign (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56536379
- GRCh38:
- Chr16:56502467
| BBS2 | | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Likely benign (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56553641
- GRCh38:
- Chr16:56519729
| BBS2 | | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Likely benign (Dec 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56531642
- GRCh38:
- Chr16:56497730
| BBS2 | | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Likely benign (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56544751
- GRCh38:
- Chr16:56510839
| BBS2 | | Retinitis pigmentosa 74, Bardet-Biedl syndrome 2, Bardet-Biedl syndrome
| Likely benign (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56548368
- GRCh38:
- Chr16:56514456
| BBS2 | | Bardet-Biedl syndrome, Retinitis pigmentosa 74, Bardet-Biedl syndrome 2
| Likely benign (Apr 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56532465
- GRCh38:
- Chr16:56498553
| BBS2 | G515C | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, not provided, Bardet-Biedl syndrome | Uncertain significance (Dec 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56553714
- GRCh38:
- Chr16:56519802
| BBS2 | I21V | Bardet-Biedl syndrome, Retinitis pigmentosa 74, Bardet-Biedl syndrome 2
| Uncertain significance (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56533778
- GRCh38:
- Chr16:56499866
| BBS2 | R480Q | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Uncertain significance (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56531739
- GRCh38:
- Chr16:56497827
| BBS2 | M571I | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Inborn genetic diseases, Bardet-Biedl syndrome | Uncertain significance (Apr 19, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56518744
- GRCh38:
- Chr16:56484832
| BBS2 | R699W | Retinitis pigmentosa 74, Bardet-Biedl syndrome 2, Bardet-Biedl syndrome
| Uncertain significance (Mar 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56543855
- GRCh38:
- Chr16:56509943
| BBS2 | | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Likely benign (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56539944
- GRCh38:
- Chr16:56506032
| BBS2 | K241T | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Uncertain significance (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56548390
- GRCh38:
- Chr16:56514478
| BBS2 | N107S | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Uncertain significance (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56536388
- GRCh38:
- Chr16:56502476
| BBS2 | | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56535282
- GRCh38:
- Chr16:56501370
| BBS2 | R403L | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Uncertain significance (Mar 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56535300
- GRCh38:
- Chr16:56501388
| BBS2 | T397I | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Uncertain significance (May 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56536335
- GRCh38:
- Chr16:56502423
| BBS2 | R325K | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Uncertain significance (Sep 25, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56548431-56548432
- GRCh38:
- Chr16:56514519-56514520
| BBS2 | V94fs | Bardet-Biedl syndrome 2, Bardet-Biedl syndrome | Pathogenic (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56531687-56531690
- GRCh38:
- Chr16:56497775-56497778
| BBS2 | V588fs | Bardet-Biedl syndrome 2, Bardet-Biedl syndrome | Pathogenic/Likely pathogenic (Sep 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56533689
- GRCh38:
- Chr16:56499777
| BBS2 | | Bardet-Biedl syndrome 2 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr16:56553776
- GRCh38:
- Chr16:56519864
| BBS2 | | not specified, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, not provided | Uncertain significance (Aug 28, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56545162
- GRCh38:
- Chr16:56511250
| BBS2 | T127R | Inborn genetic diseases, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome, not provided | Uncertain significance (Dec 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56531727
- GRCh38:
- Chr16:56497815
| BBS2 | F575fs | Bardet-Biedl syndrome 2 | Likely pathogenic (Jul 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56535321
- GRCh38:
- Chr16:56501409
| BBS2 | S390I | Retinitis pigmentosa 74, Bardet-Biedl syndrome 2 | Uncertain significance (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56519588
- GRCh38:
- Chr16:56485676
| BBS2 | Y658C | Retinitis pigmentosa 74, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome 2 | Uncertain significance (Mar 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56518695
- GRCh38:
- Chr16:56484783
| BBS2 | R715Q | Retinitis pigmentosa 74, Bardet-Biedl syndrome 2, Bardet-Biedl syndrome
| Uncertain significance (Sep 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56540190
- GRCh38:
- Chr16:56506278
| BBS2 | | not provided, Retinitis pigmentosa 74, Bardet-Biedl syndrome 2
| Benign (Jun 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56532385
- GRCh38:
- Chr16:56498473
| BBS2 | | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Likely benign (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56536376
- GRCh38:
- Chr16:56502464
| BBS2 | | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Likely benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56553651
- GRCh38:
- Chr16:56519739
| BBS2 | | Retinitis pigmentosa 74, Bardet-Biedl syndrome 2, Bardet-Biedl syndrome
| Likely benign (Jun 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56536374
- GRCh38:
- Chr16:56502462
| BBS2 | | Retinitis pigmentosa 74, Bardet-Biedl syndrome 2, Bardet-Biedl syndrome
| Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56545054
- GRCh38:
- Chr16:56511142
| BBS2 | | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Likely benign (Oct 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56533804
- GRCh38:
- Chr16:56499892
| BBS2 | | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Likely benign (Aug 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56519489-56519490
- GRCh38:
- Chr16:56485577-56485578
| BBS2 | | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Likely benign (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56532478
- GRCh38:
- Chr16:56498566
| BBS2 | | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Likely benign (Oct 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56532358-56532359
- GRCh38:
- Chr16:56498446-56498447
| BBS2 | L550fs | Bardet-Biedl syndrome, Retinitis pigmentosa 74, Bardet-Biedl syndrome 2
| Pathogenic/Likely pathogenic (Apr 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56545105
- GRCh38:
- Chr16:56511193
| BBS2 | G146fs | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 | Pathogenic/Likely pathogenic (Apr 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56540137
- GRCh38:
- Chr16:56506225
| BBS2 | | Bardet-Biedl syndrome | Pathogenic (Jun 7, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56553659
- GRCh38:
- Chr16:56519747
| BBS2 | K39R | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Uncertain significance (Aug 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56553707
- GRCh38:
- Chr16:56519795
| BBS2 | R23L | Bardet-Biedl syndrome | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56530973
- GRCh38:
- Chr16:56497061
| BBS2 | V606L | Bardet-Biedl syndrome | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56536674
- GRCh38:
- Chr16:56502762
| BBS2 | N284S | Bardet-Biedl syndrome | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56534830
- GRCh38:
- Chr16:56500918
| BBS2 | I445V | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Uncertain significance (May 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56534782
- GRCh38:
- Chr16:56500870
| BBS2 | V461M | Retinitis pigmentosa 74, Bardet-Biedl syndrome 2, Bardet-Biedl syndrome
| Uncertain significance (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56531779
- GRCh38:
- Chr16:56497867
| BBS2 | T558I | Bardet-Biedl syndrome | Uncertain significance (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56535351
- GRCh38:
- Chr16:56501439
| BBS2 | N380S | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Uncertain significance (Feb 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56536347
- GRCh38:
- Chr16:56502435
| BBS2 | T321K | Bardet-Biedl syndrome | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56553767
- GRCh38:
- Chr16:56519855
| BBS2 | L3P | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Uncertain significance (Mar 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56539951
- GRCh38:
- Chr16:56506039
| BBS2 | | Bardet-Biedl syndrome | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56544823
- GRCh38:
- Chr16:56510911
| BBS2 | D161G | Bardet-Biedl syndrome | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56544820
- GRCh38:
- Chr16:56510908
| BBS2 | N162S | Bardet-Biedl syndrome, Retinitis pigmentosa 74, Bardet-Biedl syndrome 2
| Uncertain significance (Jun 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56530880
- GRCh38:
- Chr16:56496968
| BBS2 | M637L | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, Bardet-Biedl syndrome
| Uncertain significance (Jan 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56545072
- GRCh38:
- Chr16:56511160
| BBS2 | T157M | Bardet-Biedl syndrome | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56530910
- GRCh38:
- Chr16:56496998
| BBS2 | G627R | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2, Retinitis pigmentosa 74
| Uncertain significance (Aug 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56532393
- GRCh38:
- Chr16:56498481
| BBS2 | R539W | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74, not provided, Bardet-Biedl syndrome | Uncertain significance (Mar 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56553720
- GRCh38:
- Chr16:56519808
| BBS2 | V19M | Bardet-Biedl syndrome | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56536612
- GRCh38:
- Chr16:56502700
| BBS2 | L305V | Bardet-Biedl syndrome | Uncertain significance (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56534923
- GRCh38:
- Chr16:56501011
| BBS2 | A414T | Bardet-Biedl syndrome | Uncertain significance (Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56533700
- GRCh38:
- Chr16:56499788
| BBS2 | R506Q | Bardet-Biedl syndrome | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56548568
- GRCh38:
- Chr16:56514656
| BBS2 | R48W | Bardet-Biedl syndrome 2, Retinitis pigmentosa 74 | Uncertain significance (Nov 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56548493
- GRCh38:
- Chr16:56514581
| BBS2 | Q73* | Bardet-Biedl syndrome 2 | Likely pathogenic (Apr 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56548421
- GRCh38:
- Chr16:56514509
| BBS2 | Q97* | Bardet-Biedl syndrome 2 | Likely pathogenic (Mar 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56548408
- GRCh38:
- Chr16:56514496
| BBS2 | L101* | Bardet-Biedl syndrome 2 | Likely pathogenic (Jan 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56548367
- GRCh38:
- Chr16:56514455
| BBS2 | E115* | Bardet-Biedl syndrome 2 | Likely pathogenic (Mar 30, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56544808
- GRCh38:
- Chr16:56510896
| BBS2 | L166* | Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 | Pathogenic/Likely pathogenic (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:56543898
- GRCh38:
- Chr16:56509986
| BBS2 | E195* | Bardet-Biedl syndrome 2 | Likely pathogenic (Feb 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56539945
- GRCh38:
- Chr16:56506033
| BBS2 | K241* | Bardet-Biedl syndrome 2 | Likely pathogenic (Mar 31, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56536243
- GRCh38:
- Chr16:56502331
| BBS2 | E356* | Bardet-Biedl syndrome 2 | Likely pathogenic (Apr 6, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56533815
- GRCh38:
- Chr16:56499903
| BBS2 | Q468* | Bardet-Biedl syndrome 2 | Likely pathogenic (Dec 16, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:56531674
- GRCh38:
- Chr16:56497762
| BBS2 | L593* | Bardet-Biedl syndrome 2 | Likely pathogenic (Mar 26, 2019) | criteria provided, single submitter |